These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19588916)

  • 1. Inhibitor of apoptosis (IAP) proteins: novel insights into the cancer-relevant targets for cell death induction.
    Fulda S
    ACS Chem Biol; 2009 Jul; 4(7):499-501. PubMed ID: 19588916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
    Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
    ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
    Ndubaku C; Cohen F; Varfolomeev E; Vucic D
    Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
    Vince JE; Wong WW; Khan N; Feltham R; Chau D; Ahmed AU; Benetatos CA; Chunduru SK; Condon SM; McKinlay M; Brink R; Leverkus M; Tergaonkar V; Schneider P; Callus BA; Koentgen F; Vaux DL; Silke J
    Cell; 2007 Nov; 131(4):682-93. PubMed ID: 18022363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IAP antagonists: promising candidates for cancer therapy.
    Mannhold R; Fulda S; Carosati E
    Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of IAP proteins as cancer therapeutics.
    Dynek JN; Vucic D
    Cancer Lett; 2013 May; 332(2):206-14. PubMed ID: 20685035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitor of apoptosis proteins as therapeutic targets in cancer.
    Vucic D; Fairbrother WJ
    Clin Cancer Res; 2007 Oct; 13(20):5995-6000. PubMed ID: 17947460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers.
    Fulda S
    Cancer Treat Rev; 2012 Oct; 38(6):760-6. PubMed ID: 22342104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livin/ML-IAP as a new target for cancer treatment.
    Liu B; Han M; Wen JK; Wang L
    Cancer Lett; 2007 Jun; 250(2):168-76. PubMed ID: 17218055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.
    de Almagro MC; Vucic D
    Exp Oncol; 2012 Oct; 34(3):200-11. PubMed ID: 23070005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smac mimetics as IAP antagonists.
    Fulda S
    Semin Cell Dev Biol; 2015 Mar; 39():132-8. PubMed ID: 25550219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic application.
    Fulda S
    Clin Cancer Res; 2014 Jan; 20(2):289-95. PubMed ID: 24270683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of apoptosis catch ubiquitin.
    Rajalingam K; Dikic I
    Biochem J; 2009 Jan; 417(1):e1-3. PubMed ID: 19061481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule pan-IAP antagonists: a patent review.
    Flygare JA; Fairbrother WJ
    Expert Opin Ther Pat; 2010 Feb; 20(2):251-67. PubMed ID: 20100005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in studies on inhibitor of apoptosis proteins and cancer therapy].
    Wang XH; Fu LW
    Yao Xue Xue Bao; 2006 Feb; 41(2):103-7. PubMed ID: 16671537
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia.
    Fulda S
    Br J Haematol; 2009 May; 145(4):441-54. PubMed ID: 19298593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.
    Varfolomeev E; Vucic D
    Future Oncol; 2011 May; 7(5):633-48. PubMed ID: 21568679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.